<DOC>
	<DOCNO>NCT00688597</DOCNO>
	<brief_summary>The main purpose study determine safety tolerability three different dos AT2220 people affect Pompe disease . The study also evaluate effect AT2220 functional parameter Pompe disease .</brief_summary>
	<brief_title>Study Evaluate Safety AT2220 Pompe Disease</brief_title>
	<detailed_description>Subjects meet eligibility criterion undergo physical examination , electrocardiogram ( ECG ) , spirometry , muscular strength test , functional muscle test , 6-minute walk test ( 6MWT ) ( appropriate ) , laboratory test , MRI muscle ( needle ) biopsy . Quality life assess via SF-36 questionnaire . Functional ability level handicap assess Rotterdam handicap scale .</detailed_description>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>1 . Male female , 18 74 year age inclusive 2 . Diagnosis Pompe disease base clinical assessment , enzyme assay , and/or genotyping . Confirmatory genotyping perform subject screen study . 3 . Naïve ERT receive ERT 3 month prior screen 4 . Willing initiate ERT prohibit treatment study participation 5 . Functional grade arm and/or legs ≥2 OR sit FVC ≥30 % &lt; 80 % predict value , reproducible visit 1 2 ( ± 15 % ) 6 . Subjects reproductive potential agree use reliable method contraception study 7 . Subject legal representative willing able provide write informed consent 1 . Any intercurrent condition may preclude accurate interpretation study data 2 . Obstructive pulmonary disease 3 . Invasive ventilatory support 4 . Use noninvasive ventilatory support &gt; 8 hours/day awake 5 . History QTc prolongation &gt; 450 msec male &gt; 470 msec female 6 . History allergy sensitivity study drug , include prior serious adverse reaction iminosugars ( e.g. , miglustat , miglitol ) 7 . Pregnancy breastfeed 8 . Current recent drug alcohol abuse 9 . Treatment another investigational drug within 30 day study start 10 . Use prohibit medication ≤3 month prior screen 11 . Otherwise unsuitable study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Pompe Disease</keyword>
</DOC>